IVNC-DCM (n=20) | DCM (n=32) | Delta (6 months' follow-up-baseline) | |||||||
Baseline | 6 Months' follow-up | p Value | Baseline | 6 Months' follow-up | p Value | IVNC-DCM | DCM | p Value | |
LVEDV (ml) | 233 | 161 | 0.004 | 230 | 193 | 0.166 | −57 | −10 | 0.042 |
185–315 | 143–240 | 174–285 | 173–248 | −87−11 | −59–22 | ||||
LVESV (ml) | 195 | 122 | 0.002 | 178 | 136 | 0.031 | −49 | −18 | 0.044 |
140–252 | 94–174 | 130–219 | 111–190 | −84−12 | −55–18 | ||||
LVEF (%) | 22 | 30 | 0.002 | 25 | 31 | 0.001 | 9 | 5 | 0.15 |
20–24 | 24–36 | 21–30 | 25–36 | 2–15 | 0–10 | ||||
LV dyssynchrony (ms) | 60 | 5 | <0.001 | 52 | 10 | <0.001 | −45 | −40 | 0.41 |
26–85 | −10–15 | 35–75 | −4–25 | −95−15 | −64−11 |
DCM, dilated cardiomyopathy; IVNC, isolated left ventricular non-compaction; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume.